In humans, intranasal oxytocin treatment in PTSD patients decreases provoked total symptoms in a randomized controlled trial, especially in avoidance, showing positive effects on the intensity of provoked PTSD symptoms (Sack et al., 2017). This evidence concerns the gene OXT and post-traumatic stress disorder.